A database analysis by the Early Breast Cancer Trials Collaborative Group (EBCTCG ) showed that obesity in early-stage breast cancer was only associated with increased breast cancer mortality in pre- and perimenopausal hormone receptor-positive (HR+) patients. A new study with a much larger patient population has now been presented at the SABCS [1].
Autoren
- Birke Dikken
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Atopic Dermatitis: Precisely Targeting Immunological Targets
Interleukin blockade or OX40-(L) inhibition?
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Across All Types of Cancer
Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
- Obesity: More than half of those affected have fatty liver disease
From screening to multimodal intervention with GLP-1-RA or resmetirom
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Preclinical Study on a Special Ginkgo biloba Extract
What role do proanthocyanidins play?
- Myasthenia gravis: immunomodulatory therapies for long-term treatment
Expanded Possibilities Thanks to Innovative Classes of Active Ingredients
- Interstitial Lung Diseases